These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 1397550)

  • 1. Use of chemical cleavage to release active HIV-1 proteinase from a fusion protein produced in the form of insoluble inclusion bodies.
    Gaskin DJ; Wilderspin AF
    Biochem Soc Trans; 1992 May; 20(2):162S. PubMed ID: 1397550
    [No Abstract]   [Full Text] [Related]  

  • 2. Expression of HIV-1 proteinase in E. coli.
    Gaskin DJ; Wilderspin AF
    Biochem Soc Trans; 1991 Aug; 19(3):298S. PubMed ID: 1783138
    [No Abstract]   [Full Text] [Related]  

  • 3. Autoprocessing of the HIV-1 protease using purified wild-type and mutated fusion proteins expressed at high levels in Escherichia coli.
    Louis JM; McDonald RA; Nashed NT; Wondrak EM; Jerina DM; Oroszlan S; Mora PT
    Eur J Biochem; 1991 Jul; 199(2):361-9. PubMed ID: 2070793
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [HIV-1 proteinase mutant with an altered region of the active center].
    Dergousova NI; Rumsh LD; Andreeva NS
    Mol Biol (Mosk); 1998; 32(4):678-85. PubMed ID: 9785574
    [No Abstract]   [Full Text] [Related]  

  • 5. An efficient procedure for the expression and purification of HIV-1 protease from inclusion bodies.
    Nguyen HL; Nguyen TT; Vu QT; Le HT; Pham Y; Trinh PL; Bui TP; Phan TN
    Protein Expr Purif; 2015 Dec; 116():59-65. PubMed ID: 26231073
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High-level production of active HIV-1 protease in Escherichia coli.
    Rangwala SH; Finn RF; Smith CE; Berberich SA; Salsgiver WJ; Stallings WC; Glover GI; Olins PO
    Gene; 1992 Dec; 122(2):263-9. PubMed ID: 1487142
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Purification and characterization of naturally occurring HIV-1 (South African subtype C) protease mutants from inclusion bodies.
    Maseko SB; Natarajan S; Sharma V; Bhattacharyya N; Govender T; Sayed Y; Maguire GE; Lin J; Kruger HG
    Protein Expr Purif; 2016 Jun; 122():90-6. PubMed ID: 26917227
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Site-directed mutagenesis of HIV-1 protease: generation of mutant proteases with increased stability to autodigestion.
    Tomasselli AG; Mildner AM; Rothrock DJ; Sarcich JL; Lull J; Leone J; Heinrikson R
    Adv Exp Med Biol; 1995; 362():473-7. PubMed ID: 8540360
    [No Abstract]   [Full Text] [Related]  

  • 9. HIV-1 protease variants from 100-fold drug resistant clinical isolates: expression, purification, and crystallization.
    Vickrey JF; Logsdon BC; Proteasa G; Palmer S; Winters MA; Merigan TC; Kovari LC
    Protein Expr Purif; 2003 Mar; 28(1):165-72. PubMed ID: 12651121
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Optimized Procedure for Recovering HIV-1 Protease (C-SA) from Inclusion Bodies.
    Maseko SB; Govender D; Govender T; Naicker T; Lin J; Maguire GEM; Kruger HG
    Protein J; 2019 Feb; 38(1):30-36. PubMed ID: 30666487
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of an autoprocessing CAT-HIV-1 proteinase fusion protein: purification to homogeneity of the release 99 residue proteinase.
    Montgomery DS; Singh OM; Gray NM; Dykes CW; Weir MP; Hobden AN
    Biochem Biophys Res Commun; 1991 Mar; 175(3):784-94. PubMed ID: 2025253
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Two-Step Preparation of Highly Pure, Soluble HIV Protease from Inclusion Bodies Recombinantly Expressed in Escherichia coli.
    Sherry D; Worth R; Sayed Y
    Curr Protoc Protein Sci; 2020 Jun; 100(1):e106. PubMed ID: 32339408
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genetic approaches designed to minimize cytotoxicity of retroviral protease.
    Rizzo CJ; Korant BD
    Methods Enzymol; 1994; 241():16-29. PubMed ID: 7854177
    [No Abstract]   [Full Text] [Related]  

  • 14. Cloning, expression, and mutagenesis of SIVmac proteinase in E. coli.
    Corr BR; Richardson M; Wilderspin AF
    Biochem Soc Trans; 1992 May; 20(2):160S. PubMed ID: 1397549
    [No Abstract]   [Full Text] [Related]  

  • 15. Human immunodeficiency virus type 1 and type 2 protease monomers are functionally interchangeable in the dimeric enzymes.
    Patterson CE; Seetharam R; Kettner CA; Cheng YS
    J Virol; 1992 Feb; 66(2):1228-31. PubMed ID: 1731102
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression and purification of active form of HIV-1 protease from E.coli.
    Wan M; Loh BN
    Biochem Mol Biol Int; 1995 Apr; 35(4):899-912. PubMed ID: 7627139
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of simian immunodeficiency virus (SIVmac) proteinase in E. coli.
    Sugrue RJ; Wilderspin AF
    Biochem Soc Trans; 1992 May; 20(2):161S. PubMed ID: 1327907
    [No Abstract]   [Full Text] [Related]  

  • 18. Purification of HIV-1 wild-type protease and characterization of proteolytically inactive HIV-1 protease mutants by pepstatin A affinity chromatography.
    Wondrak EM; Louis JM; Mora PT; Oroszlan S
    FEBS Lett; 1991 Mar; 280(2):347-50. PubMed ID: 2013336
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression, characterisation and mutagenesis of the aspartic proteinase from equine infectious anaemia virus.
    Powell DJ; Bur D; Wlodawer A; Gustchina A; Payne SL; Dunn BM; Kay J
    Eur J Biochem; 1996 Oct; 241(2):664-74. PubMed ID: 8917470
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cloning, expression and purification of a recombinant poly-histidine-linked HIV-1 protease.
    Leuthardt A; Roesel JL
    FEBS Lett; 1993 Jul; 326(1-3):275-80. PubMed ID: 8325379
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.